Additionally, we evaluated the effectiveness of Arid4b‐mediated in vivo DA reprogramming for reversing the phenotypes in a second PD model, where one hemisphere of the midbrain is damaged with 6‐hydroxydopamine (6‐OHDA). This evidence concerns the gene ARID4B and Parkinson disease.